KIMBERLY MORRISON: Open Payments
NPI 1609938166 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$865 in 14 payments from 10 companies in 2025. Trend: 2023 $1,031 · 2024 $797 · 2025 $865
Food & beverage: $865
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $154 |
| Novocure Inc. | 1 | $133 |
| Incyte Corporation | 1 | $132 |
| Stemline Therapeutics Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $91 |
| ABBVIE INC. | 2 | $45 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Genentech USA, Inc. | 1 | $21 |
| Caris MPI, Inc. | 1 | $18 |
Products named: Optune Lua (NovoTTF-200T), Jakafi, Orserdu, ALUNBRIG, OJJAARA, DATROWAY, ELAHERE, ZEJULA.
Industry payments across FL — which companies pay providers there.
